Track the Tissue Regenix Group plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are quoted on UK GB, under the oversight of RNS (LSE). The latest transaction was disclosed on 15 September 2023 (Purchase). Among the most active insiders: Brian Phillips. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Tissue Regenix Group plc is a company focused on tissue regeneration, providing innovative solutions for regenerative medicine. It is listed on the London Stock Exchange under the ticker XLON.